Notably, certain pharmacological treatments, such as insulin, metformin, and DPP-4 inhibitors, may modify the biological response of diabetic patients during orthodontic treatment, in some cases attenuating the bone remodeling and inflammation that are characteristic of this metabolic disease. The gene discussed is INS; the disease is metabolic disease.